Cargando…
Development and Validation of an RP-HPLC Method for CB13 Evaluation in Several PLGA Nanoparticle Systems
A simple, fast, and reversed-phase high-performance liquid chromatographic (RP-HPLC) method has been developed and validated for determining of a cannabinoid derivate, which displays potent antihyperalgesic activity, 1-naphthalenyl[4-(pentyloxy)-1-naphthalenyl]methanone (CB13) into PLGA nanoparticle...
Autores principales: | Álvarez-Fuentes, J., Martín-Banderas, L., Muñoz-Rubio, I., Holgado, M. A., Fernández-Arévalo, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Scientific World Journal
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3385602/ https://www.ncbi.nlm.nih.gov/pubmed/22792051 http://dx.doi.org/10.1100/2012/737526 |
Ejemplares similares
-
Cannabinoid derivate-loaded PLGA nanocarriers for oral administration: formulation, characterization, and cytotoxicity studies
por: Martín-Banderas, Lucía, et al.
Publicado: (2012) -
Development and Validation of New RP-HPLC Method for the Determination of Dexrazoxane
por: Basaveswara Rao, M. V., et al.
Publicado: (2012) -
Development and Validation of Stability Indicating RP-HPLC Method for Voriconazole
por: Khetre, A. B., et al.
Publicado: (2009) -
Development and Validation of a RP-HPLC Method for Determination of Cyclosporine in Capsule
por: Aziz, F., et al.
Publicado: (2010) -
Development and Validation of RP-HPLC Method for Simultaneous Determination of Granisetron and Dexamethasone
por: Heda, A. A., et al.
Publicado: (2011)